EA201200185A1 - Фармацевтическая композиция для пероральной доставки дииндолилметана - Google Patents
Фармацевтическая композиция для пероральной доставки дииндолилметанаInfo
- Publication number
- EA201200185A1 EA201200185A1 EA201200185A EA201200185A EA201200185A1 EA 201200185 A1 EA201200185 A1 EA 201200185A1 EA 201200185 A EA201200185 A EA 201200185A EA 201200185 A EA201200185 A EA 201200185A EA 201200185 A1 EA201200185 A1 EA 201200185A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- diindolylmethane
- pharmaceutical composition
- oral delivery
- block copolymer
- block
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области фармации. Описываются блок-сополимерные фармацевтические композиции с 3,3'-дииндолилметаном (DIM). Фармацевтическая композиция для перорального введения содержит 3,3'-дииндолилметан в качестве активного компонента и целевую добавку, причем она содержит в качестве целевой добавки блок-сополимер оксиэтилена и оксипропилена, в котором содержание гидрофобного блока составляет менее 50 мас.%, а молекулярная масса гидрофильного блока составляет 2250 Да и более, при соотношении активного компонента и выбранного блок-сополимера 10:1-2:1. Композиции улучшают абсорбцию активного соединения в кровоток при его пероральной доставке.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009134872/15A RU2409363C9 (ru) | 2009-09-18 | 2009-09-18 | Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций |
PCT/RU2010/000487 WO2011034465A1 (ru) | 2009-09-18 | 2010-09-07 | Фармацевтическая композиция для пероральной доставки дииндолилметана |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201200185A1 true EA201200185A1 (ru) | 2012-07-30 |
EA020932B1 EA020932B1 (ru) | 2015-02-27 |
Family
ID=43758874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200185A EA020932B1 (ru) | 2009-09-18 | 2010-09-07 | Фармацевтическая композиция для пероральной доставки дииндолилметана |
Country Status (10)
Country | Link |
---|---|
US (2) | US8791150B2 (ru) |
EP (1) | EP2478904B1 (ru) |
JP (1) | JP2013505233A (ru) |
KR (1) | KR20120078722A (ru) |
CN (1) | CN102711755A (ru) |
CA (1) | CA2774645C (ru) |
EA (1) | EA020932B1 (ru) |
RU (1) | RU2409363C9 (ru) |
UA (1) | UA102187C2 (ru) |
WO (1) | WO2011034465A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201105050D0 (en) * | 2011-03-25 | 2011-05-11 | Iiaa Ltd | Pharmaceutical agent |
RU2494733C1 (ru) | 2012-10-16 | 2013-10-10 | Всеволод Иванович Киселев | Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты) |
WO2015042170A1 (en) | 2013-09-17 | 2015-03-26 | Wayne State University | Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds |
ITMI20131924A1 (it) * | 2013-11-20 | 2015-05-21 | Cosmo Technologies Ltd | Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica |
RU2564438C1 (ru) * | 2014-07-07 | 2015-09-27 | Закрытое акционерное общество "ИльмиксГрупп" (далее - ЗАО "ИльмиксГрупп") | Способ лечения простатической интраэпителиальной неоплазии (пин) |
AU2016245984B2 (en) | 2015-04-10 | 2021-03-25 | Bioresponse, L.L.C. | Self-emulsifying formulations of DIM-related indoles |
WO2017001979A1 (en) * | 2015-06-27 | 2017-01-05 | Reform Bio Inc. | Diindolyl methane compositions, formulations and use thereof |
GB2565492A (en) * | 2016-05-16 | 2019-02-13 | Nordic Labs Ltd | Means for treating sexually-transmitted infectious diseases |
JP7169591B2 (ja) * | 2016-09-15 | 2022-11-11 | スキンテック ライフ サイエンス リミテッド | 皮膚疾患の処置のためのdimの舌下又は頬側の投与 |
JP6644017B2 (ja) * | 2017-03-30 | 2020-02-12 | 長弘生物科技股▲ふん▼有限公司 | ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277410B1 (en) * | 1992-10-08 | 2001-08-21 | Supratek Pharma Inc. | Copolymer compositions for oral delivery |
US6086915A (en) * | 1998-04-01 | 2000-07-11 | Bioresponse L.L.C. | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
US7384971B2 (en) * | 1999-09-23 | 2008-06-10 | Bioresponse L.L.C. | Phytochemicals for the treatment of cervical dysplasia |
US6416793B1 (en) * | 2000-07-11 | 2002-07-09 | Bioresponse, L.L.C. | Formulations and use of controlled-release indole alkaloids |
US8080577B2 (en) * | 2004-05-06 | 2011-12-20 | Bioresponse, L.L.C. | Diindolylmethane formulations for the treatment of leiomyomas |
EP1817019A1 (en) * | 2004-11-30 | 2007-08-15 | Myriad Genetics, Inc. | Therapeutic formulations |
RU2318509C2 (ru) | 2006-02-10 | 2008-03-10 | Всеволод Иванович Киселев | Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний |
CA2755014A1 (en) * | 2008-03-10 | 2009-09-17 | University Of Louisville Research Foundation, Inc. | Methods and compositions for controlled delivery of phytochemical agents |
-
2009
- 2009-09-18 RU RU2009134872/15A patent/RU2409363C9/ru active
-
2010
- 2010-09-07 CN CN2010800524064A patent/CN102711755A/zh active Pending
- 2010-09-07 JP JP2012529708A patent/JP2013505233A/ja active Pending
- 2010-09-07 KR KR1020127010004A patent/KR20120078722A/ko not_active Application Discontinuation
- 2010-09-07 US US13/377,261 patent/US8791150B2/en not_active Expired - Fee Related
- 2010-09-07 EP EP10817500.1A patent/EP2478904B1/en not_active Not-in-force
- 2010-09-07 EA EA201200185A patent/EA020932B1/ru not_active IP Right Cessation
- 2010-09-07 UA UAA201204644A patent/UA102187C2/ru unknown
- 2010-09-07 WO PCT/RU2010/000487 patent/WO2011034465A1/ru active Application Filing
- 2010-09-07 CA CA2774645A patent/CA2774645C/en not_active Expired - Fee Related
-
2014
- 2014-06-20 US US14/310,768 patent/US20140303225A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2774645A1 (en) | 2011-03-24 |
UA102187C2 (ru) | 2013-06-10 |
EP2478904A1 (en) | 2012-07-25 |
US20130065933A1 (en) | 2013-03-14 |
RU2409363C1 (ru) | 2011-01-20 |
US20140303225A1 (en) | 2014-10-09 |
CN102711755A (zh) | 2012-10-03 |
EA020932B1 (ru) | 2015-02-27 |
JP2013505233A (ja) | 2013-02-14 |
KR20120078722A (ko) | 2012-07-10 |
RU2409363C9 (ru) | 2013-12-10 |
WO2011034465A1 (ru) | 2011-03-24 |
CA2774645C (en) | 2018-10-09 |
EP2478904A4 (en) | 2013-03-06 |
EP2478904B1 (en) | 2016-03-16 |
US8791150B2 (en) | 2014-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200185A1 (ru) | Фармацевтическая композиция для пероральной доставки дииндолилметана | |
EA201390409A1 (ru) | Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием | |
ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
WO2007027941A3 (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
EA200901319A1 (ru) | Композиции для назального введения | |
WO2011038278A3 (en) | Micelle encapsulation of therapeutic agents | |
EA200870219A1 (ru) | Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения | |
DE602005025755D1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
WO2010100200A3 (en) | Lyophilised antibody formulation | |
EA201190012A1 (ru) | Твердые лекарственные формы бендамустина | |
UA110013C2 (uk) | Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів | |
EA200800360A1 (ru) | Формуляции с высоким содержанием лекарства и дозированные формы | |
TR200806298A2 (tr) | Farmasötik formülasyon | |
EA201291410A1 (ru) | Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат | |
MY143549A (en) | Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases | |
EA201290985A1 (ru) | Пероральные ветеринарные фармацевтические и нутрицевтические композиции | |
EA201300539A1 (ru) | Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая | |
EA201100430A1 (ru) | Стабильная комбинированная фармацевтическая композиция | |
US9474723B2 (en) | Anti-microbial composition | |
CY1120050T1 (el) | Φαρμακοτεχνικες μορφες για την αποδεσμευση δραστικων ενωσεων | |
WO2013066208A3 (ru) | Фармацевтическая композиция на основе наномицелл, содержащих эпигаллокатехингаллат, и ее применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KG MD TJ TM RU |
|
TC4A | Change in name of a patent proprietor in a eurasian patent |